Passive and iontophoretic delivery of bifonazole loaded Liposomal formulation: A comparative study
Keywords:
Bifonazole, Liposome, soya lecithin, iontophoresis, passive diffusion and fungal infectionAbstract
Fungal infections are one of the most common dermatological conditions worldwide. The goal of this study was to create and test a liposomal version of the antifungal medication Bifonazole. The thin film approach was used to make nine batches of Bifonazole liposomal gel, each with a different ratio of cholesterol, soya lecithin, and stearyl amine. It was investigated how formulation variables affected entrapment efficiency, particle size, surface charge, and drug release behaviour. The addition of a positively charged surfactant like stearyl amine improves the entrapment effectiveness of Bifonazole into liposomes considerably. When compared to the other formulations, the LFG8 formulation had the highest drug-loading capacity (83.210.69%). After 24 hours, the total amount of medication released from the Bifonazole liposomal gel ranged from 51.520.67% to 83.210.69%. The molar ratio of soya lecithin in the formulation rose, delaying drug release. This may be due to Bifonazole's interaction with the vast surface area of the liposome's lipid bilayer membrane and the thickness and fluidity of the soya lecithin layer. In an ex-vivo skin permeation investigation, it was discovered that iontophoretic administration had superior penetration than passive diffusion. Iontophoresis dramatically enhances the amount of medication that is absorbed through the skin.
Downloads
References
Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12(4):758-91.
Ghasemiyeh P, Mohammadi-Samani S. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: Advantages and disadvantages. Drug Des Devel Ther. 2020;14:3271-89.
Yu YQ, Yang X, Wu XF, Fan YB. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: Novel strategies for effective transdermal applications. Front Bioeng Biotechnol. 2021;9:646554.
Badkar AV, Betageri GV, Hofmann GA, Banga AK. Enhancement of transdermal iontophoretic delivery of a liposomal formulation of Colchicine by electroporation. Drug Deliv. 1999;6(2):111-5.
Cross SE, Roberts MS. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development?. Curr Drug Deliv. 2004;1(1):81-92.
Teong B, Kuo SM, Tsai WH, Ho ML, Chen CH, Huang HH. Liposomal encapsulation for systemic delivery of propranolol via transdermal iontophoresis improves bone microarchitecture in ovariectomized rats. Int J Mol Sci. 2017;18(4):822.
Pawar HA, Attarde VB. Study of effect of formulation variables on Bifonazole niosomes by applying Plackett burman design. Austin J Anal Pharm Chem. 2017;4(1):1-5.
Sahoo CK, Satyanarayana K, Bomma NG, Modugu KR, Nayak PK, Sarangi DK. Formulation and evaluation of Bifonazole organogel for the application of topical drug delivery system. Int J Med Pharm Res. 2013; 1(1):170‐8.
Moghimipour E, Salami A, Monjezi M. Formulation and evaluation of liposomes for transdermal delivery of Celecoxib. Jundishapur J Nat Pharm Prod. 2015;10(1):1-6.
Mohammadi-Samani S, Montaseri H, Jamshidnejad M. Preparation and evaluation of cyproterone acetate liposome for topical drug delivery. Iran J Pharm Sci. 2009;5(4):199-204.
Siddoju S, Sachdeva V, Friden PM, Banga AK. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery. Ther Deliv. 2012;3(3):327-38.
Tavakoli N, Minaiyan M, Heshmatipour M, Musavinasab R. Transdermal iontophoretic delivery of celecoxib from gel formulation. Res Pharm Sci. 2015;10(5):419-28.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
